Your browser doesn't support javascript.
loading
Rationale for different formulations of omega-3 fatty acids leading to differences in residual cardiovascular risk reduction.
Mason, R Preston; Sherratt, Samuel C R; Eckel, Robert H.
Afiliación
  • Mason RP; Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, United States of America. Electronic address: rpmason@elucidaresearch.com.
  • Sherratt SCR; University of New Hampshire, Durham, NH 03823, United States of America.
  • Eckel RH; University of Colorado Anschutz Medical Campus, Aurora, CO 80045, United States of America.
Metabolism ; 130: 155161, 2022 05.
Article en En | MEDLINE | ID: mdl-35151755
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Ácidos Grasos Omega-3 Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Metabolism Año: 2022 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Enfermedades Cardiovasculares / Ácidos Grasos Omega-3 Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Metabolism Año: 2022 Tipo del documento: Article